Skip to main content

Emerson Collective — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

46
Companies
$1.5B
Total invested
$37.1M
Avg. check
50
Industries
Health Care 7Biotechnology 7Software 4Life Science 4Medical 4CleanTech 4+44 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 46
Syndio
September 2021

Syndio is a technology company that helps companies measure, achieve, and sustain workplace equity.

Analytics · Seattle$50.0M Series C
Ribbon
September 2024

AI-powered student success platform

Artificial Intelligence (AI) · Albany$400K Grant
Psych Hub
August 2022

Psych Hub is a website that offers short movies and Learning Hubs about mental health, substance abuse, and crime prevention.

Health Care · Nashville$16.0M Series A
Stipple Bio
April 2026

Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.

Biopharma · Cambridge$100.0M Series A
Anthro Energy
April 2026

Anthro Energy is a battery technology company that uses polymer electrolytes to improve the safety and adaptability of lithium-ion cells.

Battery · San Jose$24.9M Grant
Ultralight
April 2026

Ultralight is an AI-native operating system made for contemporary healthcare procedures.

Health Care · San Francisco$9.3M Seed
Macro
March 2023

Macro is a disruptive media company focused on the multicultural market.

Digital Media · Los Angeles$90.0M Private Equity
Spotlight Therapeutics
March 2022

Spotlight Therapeutics is a biotechnology company that develops biologics targeted to specific cell populations in gene editing.

Biotechnology · Hayward$36.5M Series B
Ribbon Education
February 2022

Ribbon Education is a teacher-student relationship management platform.

EdTech · Brooklyn$1.9M Seed
Walking Fish Therapeutics
February 2022

Walking Fish Therapeutics is developing a platform to harness B cells’ capability to activate the immune system.

Biotechnology · San Francisco$23.0M Series A
Resonant Link
January 2025

Resonant Link delivers the world's fastest and easiest to use wireless charging for medical devices, consumer electronics, and EVs.

Advanced Materials · South Burlington$3.4M Series A
Tune Therapeutics
January 2025

Tune Therapeutics is an epigenetic programming platform for the treatment of disease.

Biotechnology · Durham$175.0M Series B
Advex AI
November 2024

Advex AI is creating Vision AI to adapt to the dynamic real world and its various application cases.

Software · San Francisco$3.5M Seed
Ignite Reading
October 2024

Ignite Reading is a tutoring organization that helps accelerate students' reading progress with education administration programs.

Education · San Francisco$36.8M Series B
Switch Bioworks
September 2024

Switch Bioworks produces sustainable nitrogen fertilizer by reprogramming naturally occurring symbiotic microbes to produce fertilizers.

Agriculture · San Carlos$17.0M Seed
Xcimer Energy
June 2024

Xcimer Energy is an inertial fusion company offering laser-driven fusion to provide cheap, abundant, and carbon-free energy.

Energy · Denver$100.0M Series A
Atropos Health
May 2024

Atropos Health develops a clinical analytics platform that specializes in evidence-based healthcare.

Clinical Trials · New York$33.0M Series B
Eleanor Health
February 2024

Eleanor Health provides comprehensive mental health and substance use disorder care in clinics, virtually, and in patient's homes.

Health Care · Waltham$30.0M Series D
Curipod
September 2023

Curipod is an interactive presentation software for education, meetings, and workshops.

EdTech · Bergen$4.6M Seed
InduPro
January 2026

InduPro deevlops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease.

Biotechnology · SeattleCorporate Round
Nithio Holdings
January 2024

Nithio Holdings a Washington, DC-based energy finance company focused on the off-grid sector in Africa.

Energy · Washington$10.0M Debt Financing
Clade Therapeutics
November 2021

Clade Therapeutics discovers and delivers next-generation cell medicines to improve the lives of patients.

Biotechnology · Cambridge$87.0M Series A
Zap Energy
September 2024

Zap Energy is developing compact fusion power that doesn't require magnets or lasers.

Clean Energy · Everett$130.0M Series D
Aclima
September 2024

Aclima is a climate-tech company that focuses on mapping and analyzing air pollution through advanced measurement and analysis platforms.

Analytics · San Francisco$13.0M Debt Financing

Where Emerson Collective invests

Health Care7
Biotechnology7
Software4
Life Science4
Medical4
CleanTech4

About Emerson Collective's portfolio

How many companies has Emerson Collective invested in?

Emerson Collective has invested in 46 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Emerson Collective invest in?

Emerson Collective's top investment sectors include Health Care, Biotechnology, Software, Life Science, Medical. The firm invests across 50 different industry categories.

What is Emerson Collective's largest investment?

Among tracked funding rounds, Tune Therapeutics received $175.0M in a Series B round. Emerson Collective's total known invested capital is $1.5B.

What is the average investment size for Emerson Collective?

Emerson Collective's average investment size is $37.1M across its portfolio of 46 companies.

What are Emerson Collective's most recent investments?

Recent Emerson Collective portfolio additions include Syndio, Ribbon, Psych Hub, Stipple Bio, Anthro Energy. These companies were founded in 2020 or later.

Reach the founders behind these 46 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →